Manufacturers Life Insurance Company, The Coherus Bio Sciences, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.58 - $2.51 $10,110 - $16,061
6,399 Added 16.73%
44,645 $77,000
Q1 2024

May 14, 2024
BUY
$2.02 - $3.14 $753 - $1,171
373 Added 0.98%
38,246 $91,000
Q3 2023

Nov 15, 2023
BUY
$3.74 - $5.45 $20,801 - $30,312
5,562 Added 17.21%
37,873 $141,000
Q2 2023

Aug 11, 2023
BUY
$3.79 - $8.3 $11,332 - $24,817
2,990 Added 10.2%
32,311 $137,000
Q4 2022

Aug 11, 2023
SELL
$5.69 - $10.07 $819 - $1,450
-144 Reduced 0.49%
29,321 $232,000
Q4 2022

Feb 13, 2023
SELL
$5.69 - $10.07 $819 - $1,450
-144 Reduced 0.49%
29,321 $232,000
Q3 2022

Aug 11, 2023
SELL
$7.17 - $13.87 $5,277 - $10,208
-736 Reduced 2.44%
29,465 $283,000
Q3 2022

Nov 03, 2022
SELL
$7.17 - $13.87 $5,277 - $10,208
-736 Reduced 2.44%
29,465 $283,000
Q2 2022

Aug 11, 2023
BUY
$5.86 - $13.23 $17,550 - $39,623
2,995 Added 11.01%
30,201 $218,000
Q2 2022

Aug 15, 2022
BUY
$5.86 - $13.23 $17,550 - $39,623
2,995 Added 11.01%
30,201 $219,000
Q1 2022

Aug 11, 2023
SELL
$10.92 - $16.41 $23,095 - $34,707
-2,115 Reduced 7.21%
27,206 $351,000
Q1 2022

May 20, 2022
SELL
$10.92 - $16.41 $68,796 - $103,383
-6,300 Reduced 18.8%
27,206 $351,000
Q4 2021

Feb 16, 2022
SELL
$15.81 - $18.99 $10,260 - $12,324
-649 Reduced 1.9%
33,506 $535,000
Q3 2021

Nov 12, 2021
SELL
$12.68 - $17.79 $35,630 - $49,989
-2,810 Reduced 7.6%
34,155 $549,000
Q2 2021

Aug 12, 2021
BUY
$12.95 - $15.41 $38,966 - $46,368
3,009 Added 8.86%
36,965 $511,000
Q1 2021

May 03, 2021
SELL
$14.42 - $21.39 $13,251 - $19,657
-919 Reduced 2.64%
33,956 $496,000
Q4 2020

Feb 12, 2021
BUY
$16.56 - $18.94 $14,655 - $16,761
885 Added 2.6%
34,875 $606,000
Q3 2020

Nov 09, 2020
SELL
$17.41 - $19.89 $11,333 - $12,948
-651 Reduced 1.88%
33,990 $623,000
Q2 2020

Aug 10, 2020
SELL
$14.43 - $19.16 $77,157 - $102,448
-5,347 Reduced 13.37%
34,641 $600,000
Q1 2020

May 15, 2020
BUY
$11.67 - $22.53 $33,236 - $64,165
2,848 Added 7.67%
39,988 $649,000
Q4 2019

Feb 14, 2020
SELL
$16.33 - $21.37 $20,183 - $26,413
-1,236 Reduced 3.22%
37,140 $669,000
Q3 2019

Nov 12, 2019
SELL
$16.3 - $23.37 $3,178 - $4,557
-195 Reduced 0.51%
38,376 $786,000
Q2 2019

Aug 14, 2019
BUY
$13.1 - $22.1 $53,081 - $89,549
4,052 Added 11.74%
38,571 $852,000
Q1 2019

May 13, 2019
BUY
$8.38 - $15.5 $18,318 - $33,883
2,186 Added 6.76%
34,519 $471,000
Q4 2018

Feb 14, 2019
SELL
$8.65 - $16.28 $18,658 - $35,115
-2,157 Reduced 6.25%
32,333 $293,000
Q3 2018

Nov 14, 2018
SELL
$14.45 - $20.25 $22,585 - $31,650
-1,563 Reduced 4.34%
34,490 $569,000
Q2 2018

Aug 14, 2018
BUY
$10.25 - $17.45 $48,216 - $82,084
4,704 Added 15.01%
36,053 $505,000
Q1 2018

May 15, 2018
SELL
$9.1 - $13.7 $254 - $383
-28 Reduced 0.09%
31,349 $347,000
Q4 2017

Feb 08, 2018
BUY
$8.35 - $14.4 $5,819 - $10,036
697 Added 2.27%
31,377 $276,000
Q3 2017

Nov 14, 2017
BUY
$11.1 - $14.5 $340,548 - $444,860
30,680
30,680 $409,000

Others Institutions Holding CHRS

# of Institutions
135
Shares Held
77.9M
Call Options Held
40.7K
Put Options Held
50.1K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $122M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email